FindTrial
Sign In

Extracorporeal shock waves

DEVICE5 trials

Sponsors

University of Sao Paulo General Hospital, Ewha Womans University Mokdong Hospital, Sahmyook University, National Taiwan University Hospital Hsin-Chu Branch, Mariem Gaddour

Conditions

Breast CancerExercise ProgramExtracorporeal Shock Waves TherapyMusculoskeletal Diseases Nervous System DiseasesNeck PainStrokeUnilateral Primary Osteoarthritis of Knee

Phase 2

Extracorporeal Focused Shock Wave Therapy for Primary Knee Osteoarthritis
NCT02904785
University of Sao Paulo General HospitalUnilateral Primary Osteoarthritis of Knee
Start: 2016-05-31End: 2016-12-31Target: 30Updated: 2016-09-19
extracorporeal shock waves in management of lower limb spasticity in children with cerebral palsy
Active, not recruitingPACTR202504897518926
Mariem GaddourMusculoskeletal Diseases Nervous System Diseases
Start: 2024-12-02Target: 30Updated: 2026-09-14

Unknown Phase

Pilot Study to Evaluate the Prevention and Safety of Doxorubicin-induced Cardiomyopathy Using Extracorporeal Shock Waves
NCT05584163
Ewha Womans University Mokdong HospitalBreast Cancer
Start: 2020-10-01End: 2023-06-30Target: 72Updated: 2023-06-02
Effect of Extracorporeal Shockwave Therapy Before Postural Correction Exercise in Adults With Forward Head Posture
CompletedNCT05855772
Sahmyook UniversityExercise Program, Extracorporeal Shock Waves Therapy, Neck Pain
Start: 2023-05-08End: 2023-06-19Updated: 2023-09-06
Comparing ESWT Doses for Post-Stroke Ankle Spasticity Treatment
RecruitingNCT05878223
National Taiwan University Hospital Hsin-Chu BranchStroke
Start: 2022-01-01End: 2024-12-31Target: 40Updated: 2024-07-17

Related Papers

The dose effectiveness of extracorporeal shockwave on plantar flexor spasticity of ankle in stroke patients: a randomized controlled trial.
2024-10-014 citations
A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin
Frontiers in Cardiovascular Medicine2024-02-071 citations